Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gene and Protein Expression Profiles After Treatment of Actinic Keratoses

NCT05740969 is registered in ClinicalTrials.gov with Ismail Gögenur as lead sponsor.

NCT NCT05740969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05740969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gene and Protein Expression Profiles After Treatment of Actinic Keratoses
Lead sponsor
Ismail Gögenur
Phase
Phase 2
Overall status
Unknown status
Start date
February 1, 2023
Completion date
December 31, 2024
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratoses